Immune checkpoint inhibitor-induced sarcoidosis-like granulomas

Volume: 24, Issue: 10, Pages: 1171 - 1181
Published: Jul 18, 2019
Abstract
Immune checkpoint inhibitors targeting the cytotoxic T lymphocyte-associated antigen-4 and programmed cell death-1 receptors have transformed the treatment of melanoma and other cancers. These therapies are associated with a number of side effects, including immune-related adverse events. Sarcoidosis-like granulomas (SLGs) are important immune checkpoint inhibitor-related reactions to recognize as SLGs can mimic disease progression and...
Paper Details
Title
Immune checkpoint inhibitor-induced sarcoidosis-like granulomas
Published Date
Jul 18, 2019
Volume
24
Issue
10
Pages
1171 - 1181
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.